During the last decade, positron emission tomography/computed tomography (PET/CT) with 18F- or 11C-labeled choline was considered to be one of the most accurate imaging modalities available for prostate cancer recurrence with varying detection rates based on PSA values and kinetics [12]. This evidence concerns the gene KLK3 and prostate cancer.